Meeder Asset Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Meeder Asset Management’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-398	Closed	-$3K	–	1883
2017 Q2	$3K	Hold	398	–	–	﹤0.01%	1377
2017 Q1	$2K	Sell	398 -1,963	-83%	-$10.7K	﹤0.01%	1474
2016 Q4	$12K	Buy	+2,361	New	+$12.1K	﹤0.01%	738

Other funds holding OSIR

FIM

Freedom Investment Management Hartford, Connecticut $359M AUM 23.01% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return

Meeder Asset Management's OSIR Position: Q3 2017 in Review

Meeder Asset Management sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q3 2017, closing a stake of 398 shares — an estimated $3K sold.

Meeder Asset Management first reported a position in OSIR in Q4 2016 and held it in 3 quarters. The position peaked at $12K in Q4 2016. 2 funds tracked by Wall St. Rank hold OSIR as of Q3 2017.

Meeder Asset Management reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
Meeder Asset Management sold 398 Osiris Therapeutics, Inc. Common Stock shares in Q3 2017, an estimated $3K.
Meeder Asset Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q4 2016 and held it in 3 quarters.
Meeder Asset Management's Osiris Therapeutics, Inc. Common Stock position peaked at $12K in Q4 2016.
2 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q3 2017.

Based on Meeder Asset Management's 13F filing for Q3 2017, filed 20 Oct 2017.